1. A Clinical Review of Biosimilars Approved in Oncology. Issue 3 (March 2021) Authors: Ngo, Dat; Chen, Jason Journal: Annals of pharmacotherapy Issue: Volume 55:Issue 3(2021) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia. Issue 10 (October 2013) Authors: Patel, Samit; Liedtke, Michaela; Ngo, Dat; Medeiros, Bruno C. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia. Issue 5 (16th April 2019) Authors: Chen, Jason; Ngo, Dat; Aldoss, Ibrahim; Shayani, Sepideh; Tsai, Ni-Chun; Pullarkat, Vinod Journal: Leukemia & lymphoma Issue: Volume 60:Issue 5(2019) Page Start: 1187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Biosimilar Impact on Oncology Clinical Trial Design and Operations. Issue 3 (March 2022) Authors: Chen, Jason; Ngo, Dat; Yi, Annie Journal: JCO oncology practice Issue: Volume 18:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease. (December 2019) Authors: Chen, Jason; Ngo, Dat; Rosenthal, Joseph Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 8(2019) Page Start: 2027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Issue 13 (10th November 2022) Authors: Ball, Brian J.; Arslan, Shukaib; Koller, Paul; Ngo, Dat; Afkhami, Michelle; Salhotra, Amandeep; Al-Malki, Monzr; Aribi, Ahmed; Ali, Haris; Sandhu, Karamjeet; Otoukesh, Salman; Amanam, Idoroenyi; Pourhassan, Hoda; Artz, Andrew; Curtin, Peter; Stein, Anthony; Nakamura, Ryotaro; Marcucci, Guido; Smi... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 13(2022) Page Start: 3232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia. Issue 3 (11th October 2021) Authors: Aldoss, Ibrahim; Otoukesh, Salman; Zhang, Jianying; Mokhtari, Sally; Ngo, Dat; Mojtahedzadeh, Mona; Al Malki, Monzr M.; Salhotra, Amandeep; Ali, Haris; Aribi, Ahmed; Sandhu, Karamjeet S.; Arslan, Shukaib; Koller, Paul; Ball, Brian; Stewart, Forrest; Curtin, Peter; Artz, Andrew; Nakamura, Ryotaro;... Journal: Cancer Issue: Volume 128:Issue 3(2022) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fosaprepitant for the Treatment of Refractory Postoperative Nausea and Vomiting. Issue 3 (March 2015) Authors: Tran, Linh H.; Cudny, Magdalena; Ngo, Dat; Patel, Samit; Lam, Manuel Y. Journal: Hospital pharmacy Issue: Volume 50:Issue 3(2015) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Issue 13 (10th November 2022) Authors: Amanam, Idoroenyi; Ngo, Dat; Pullarkat, Vinod; Aldoss, Ibrahim Journal: Leukemia & lymphoma Issue: Volume 63:Issue 13(2022) Page Start: 3268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Levocarnitine for pegasparaginase-induced hepatotoxicity in acute lymphoblastic leukemia. Issue 13 (9th November 2020) Authors: Trang, Elena; Ngo, Dat; Chen, Jason; Aldoss, Ibrahim; Salhotra, Amandeep; Pullarkat, Vinod Journal: Leukemia & lymphoma Issue: Volume 61:Issue 13(2020) Page Start: 3161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗